Intervertebral disc tissue engineering: A brief review.


Journal

Bosnian journal of basic medical sciences
ISSN: 1840-4812
Titre abrégé: Bosn J Basic Med Sci
Pays: Bosnia and Herzegovina
ID NLM: 101200947

Informations de publication

Date de publication:
20 May 2019
Historique:
received: 29 07 2018
accepted: 29 07 2018
pubmed: 7 2 2019
medline: 18 12 2019
entrez: 7 2 2019
Statut: epublish

Résumé

Intervertebral disc (IVD) degeneration (IDD) is associated with low back pain and significantly affects the patient's quality of life. Degeneration of the IVD alters disk height and the mechanics of the spine, leading to chronic segmental spinal instability. The pathophysiology of IVD disease is still not well understood. Current therapies for IDD include conservative and invasive approaches, but none of those treatments are able to restore the disc structure and function. Recently, tissue engineering techniques emerged as a possible approach to treat IDD, by replacing a damaged IVD with scaffolds and appropriate cells. Advances in manufacturing techniques, material processing and development, surface functionalization, drug delivery systems and cell incorporation furthered the development of tissue engineering therapies. In this review, biomaterial scaffolds and cell-based therapies for IVD regeneration are briefly discussed.

Identifiants

pubmed: 30726701
doi: 10.17305/bjbms.2019.3778
pmc: PMC6535390
doi:

Substances chimiques

Biocompatible Materials 0
Polymers 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

130-137

Références

Pain. 2000 Jan;84(1):95-103
pubmed: 10601677
Artif Organs. 2001 Mar;25(3):213-7
pubmed: 11284889
Biomaterials. 2003 Feb;24(3):401-16
pubmed: 12423595
Arthritis Res Ther. 2003;5(3):120-30
pubmed: 12723977
Eur Cell Mater. 2003 May 20;5:1-16; discussion 16
pubmed: 14562275
Ann Biomed Eng. 2004 Mar;32(3):430-4
pubmed: 15095817
Biomacromolecules. 2004 May-Jun;5(3):718-26
pubmed: 15132652
Biomaterials. 2005 Jun;26(17):3385-93
pubmed: 15621227
Biomaterials. 2005 Jun;26(18):3919-28
pubmed: 15626439
Stem Cells. 2005 Mar;23(3):403-11
pubmed: 15749935
Biomaterials. 2006 Jan;27(3):335-45
pubmed: 16112726
Biomaterials. 2006 Jan;27(3):388-96
pubmed: 16125220
Eur Spine J. 2006 Aug;15 Suppl 3:S406-13
pubmed: 16845553
Adv Exp Med Biol. 2006;585:167-81
pubmed: 17120784
J Biomed Mater Res A. 2007 Sep 1;82(3):701-10
pubmed: 17326226
Eur Spine J. 2007 Nov;16(11):1848-57
pubmed: 17447088
J Biomater Appl. 2007 Nov;22(3):241-54
pubmed: 17494964
Biotechnol Adv. 2008 Jan-Feb;26(1):1-21
pubmed: 17884325
Biomaterials. 2008 Feb;29(4):438-47
pubmed: 17959242
Spine J. 2008 Nov-Dec;8(6):888-96
pubmed: 18082460
Int J Biochem Cell Biol. 2008;40(5):837-42
pubmed: 18243770
J Biomed Mater Res A. 2009 Oct;91(1):187-94
pubmed: 18785646
Eur Spine J. 2008 Dec;17 Suppl 4:480-91
pubmed: 19005701
Arthritis Res Ther. 2009;11(1):R20
pubmed: 19210770
Spine (Phila Pa 1976). 2009 Apr 20;34(9):934-40
pubmed: 19532001
Mol Ther. 2009 Nov;17(11):1959-66
pubmed: 19584814
Biomaterials. 2009 Oct;30(29):5523-33
pubmed: 19646749
J Cell Physiol. 2010 Jan;222(1):23-32
pubmed: 19725073
J Neurosurg Spine. 2009 Oct;11(4):501-7
pubmed: 19929349
J Biomech. 2010 Apr 19;43(6):1017-30
pubmed: 20080239
Acta Neurochir (Wien). 2010 Oct;152(10):1771-7
pubmed: 20571835
Wiley Interdiscip Rev Syst Biol Med. 2009 Jul-Aug;1(1):97-106
pubmed: 20835984
Regen Med. 2010 Sep;5(5):701-11
pubmed: 20868326
Eur Spine J. 2011 Apr;20(4):592-603
pubmed: 21181480
J Tissue Eng Regen Med. 2011 Jun;5(6):e97-107
pubmed: 21604382
J Tissue Eng Regen Med. 2011 Aug;5(8):e179-87
pubmed: 21774081
Tissue Eng Part A. 2012 Mar;18(5-6):447-58
pubmed: 21919790
Spine (Phila Pa 1976). 2012 Mar 15;37(6):452-8
pubmed: 22037529
J Tissue Eng Regen Med. 2012 Dec;6 Suppl 3:s24-33
pubmed: 22311816
Stem Cells Int. 2012;2012:921053
pubmed: 22550520
J Neurosurg Spine. 2012 Aug;17(2):177-83
pubmed: 22632174
Acta Biomater. 2013 Feb;9(2):5262-72
pubmed: 23000521
Spine J. 2013 Mar;13(3):243-62
pubmed: 23369494
J Tissue Eng Regen Med. 2015 Jun;9(6):679-90
pubmed: 23512973
Curr Opin Biotechnol. 2013 Oct;24(5):872-9
pubmed: 23773764
Biotechnol Adv. 2013 Dec;31(8):1514-31
pubmed: 23911974
Adv Stem Cells. 2013;2013:null
pubmed: 23951558
Bone Joint Res. 2013 Aug 19;2(8):169-78
pubmed: 23958792
Cell Transplant. 2015;24(2):133-49
pubmed: 24268069
Mol Med Rep. 2014 Feb;9(2):574-82
pubmed: 24271232
Stem Cells Int. 2013;2013:326828
pubmed: 24454406
Tissue Eng Part B Rev. 2014 Oct;20(5):492-502
pubmed: 24547761
Mater Sci Eng C Mater Biol Appl. 2014 Apr 1;37:232-40
pubmed: 24582244
J Tissue Eng Regen Med. 2015 Oct;9(10):1120-32
pubmed: 24616324
Arthritis Res Ther. 2014 Mar 12;16(2):R67
pubmed: 24618041
Nat Rev Rheumatol. 2014 Sep;10(9):561-6
pubmed: 24914695
Trends Biotechnol. 2014 Sep;32(9):433-5
pubmed: 24946697
Adv Drug Deliv Rev. 2015 Apr;84:159-71
pubmed: 24993611
Stem Cells Int. 2012;2012:897183
pubmed: 25098367
Adv Healthc Mater. 2015 Jan 28;4(2):176-94
pubmed: 25116596
Adv Drug Deliv Rev. 2015 Apr;84:146-58
pubmed: 25174310
Colloids Surf B Biointerfaces. 2014 Nov 1;123:533-41
pubmed: 25444658
Carbohydr Polym. 2015 Mar 6;117:34-42
pubmed: 25498606
Cell Physiol Biochem. 2015;35(1):1-16
pubmed: 25547527
World J Stem Cells. 2015 Jan 26;7(1):65-74
pubmed: 25621106
J R Soc Interface. 2015 Mar 6;12(104):20141191
pubmed: 25673296
Sci China Chem. 2014 Apr 1;57(4):490-500
pubmed: 25729390
Osteoarthritis Cartilage. 2015 Jul;23(7):1057-70
pubmed: 25827971
PLoS One. 2015 Apr 20;10(4):e0124774
pubmed: 25894203
Colloids Surf B Biointerfaces. 2015 Jul 1;131:122-8
pubmed: 25982316
PLoS One. 2015 Jun 26;10(6):e0131827
pubmed: 26115332
Stem Cells Int. 2015;2015:948040
pubmed: 26124844
Colloids Surf B Biointerfaces. 2015 Dec 1;136:84-92
pubmed: 26363270
Wien Klin Wochenschr. 2015 Dec;127 Suppl 5:S187-98
pubmed: 26404739
Arthritis Res Ther. 2015 Dec 25;18:29
pubmed: 26809343
Transl Pediatr. 2014 Apr;3(2):71-90
pubmed: 26835326
Stem Cells Int. 2016;2016:3908389
pubmed: 26880958
Orthop Surg. 2016 Feb;8(1):11-8
pubmed: 27028376
Sci Rep. 2016 May 24;6:26653
pubmed: 27215333
Eur Cell Mater. 2015 Oct 12;30:210-31
pubmed: 27227695
World J Stem Cells. 2016 May 26;8(5):185-201
pubmed: 27247704
Biomed Res Int. 2016;2016:5952165
pubmed: 27314030
Int J Biol Macromol. 2016 Dec;93(Pt B):1390-1401
pubmed: 27316767
Sci Rep. 2016 Jun 24;6:28695
pubmed: 27340110
Biomater Sci. 2016 Aug 16;4(9):1276-90
pubmed: 27426524

Auteurs

Janja Stergar (J)

Institute of Biomedical Sciences, Faculty of Medicine, University of Maribor, Maribor, Slovenia Laboratory of Inorganic Chemistry, Faculty of Chemistry and Chemical Technology, University of Maribor, Maribor, Slovenia. janja.stergar@um.si.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH